STOLICK DAVID 4
4 · BRAINSTORM CELL THERAPEUTICS INC · Filed Feb 23, 2010
Insider Transaction Report
Form 4
STOLICK DAVID
Chief Financial Officer
Transactions
- Sale
Common Stock
2010-02-22$0.36/sh−100,000$36,000→ 150,000 total
Footnotes (1)
- [F1]The sale, and the sales reported on the Form 4 filed on February 19, 2010, were pursuant to a 10b5-1 plan dated October 2009.